Kidney stones: a global picture of prevalence, incidence, and associated risk factors.
Victoriano Romero, Haluk Akpinar, Dean G Assimos
https://pubmed.ncbi.nlm.nih.gov/20811557Actively Recruiting
Led by University of California, Irvine · Updated on 2025-06-24
100
Participants Needed
1
Research Sites
N/A
Total Duration
Kidney stone disease is becoming more common worldwide, with calcium oxalate stones being the most frequent type in the United States, followed by uric acid stones. This research aims to evaluate whether sodium bicarbonate, a low-cost alternative to potassium citrate, can effectively increase urine citrate levels and alkalinize urine in people who form these stones. The study is a randomized, phase 1 trial focusing on preventing recurrence of kidney stones by improving urine chemistry. Participants will be randomly assigned to one of two treatment sequences: either starting with potassium citrate (Urocit-K) for four weeks followed by a washout period and then sodium bicarbonate (baking soda) for four weeks, or vice versa. Potassium citrate is taken as 30 mEq tablets twice daily, while sodium bicarbonate is taken dissolved in water or another liquid as half a teaspoon (29.5 mEq) twice daily. Urine samples will be collected at specific intervals to measure changes during each treatment period. Participants will collect 24-hour urine samples before and after each treatment phase to assess urine pH and citrate levels. Blood tests will be performed to monitor kidney function. Researchers will measure changes in urinary pH and citrate as primary outcomes, along with calcium oxalate and uric acid supersaturation as secondary outcomes. The total study duration includes treatment periods, washouts, and sample collections over approximately 12 weeks, with ongoing safety monitoring throughout.
CONDITIONS
Impact of Sodium Bicarbonate on 24-hour Urine Parameters in Hypocitriuric and Uric Acid Stone Formers
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 12 weeks including washout periods
Participants will take either potassium citrate or sodium bicarbonate for four weeks, with urine collections during the last two days of each treatment period to assess urinary changes. After a two-week washout period, participants will switch to the other treatment for another four weeks, with similar urine collections at the end.
Multiple visits including baseline, end of each 4-week treatment, and after washout periods
Total: 1 location
1
University of California, Irvine Medical Center
Orange, California, United States, 92868
Actively Recruiting
S
Sohrab N Ali, M.D
R
Renai Yoon, B.S.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Victoriano Romero, Haluk Akpinar, Dean G Assimos
https://pubmed.ncbi.nlm.nih.gov/20811557Andrew D Rule, John C Lieske, Xujian Li...
https://pubmed.ncbi.nlm.nih.gov/25104803Michael R Wiederkehr, Orson W Moe
https://pubmed.ncbi.nlm.nih.gov/25045326Vivian Barbosa Pinheiro, Alessandra Calábria Baxmann, Hans-Göran Tiselius...
https://pubmed.ncbi.nlm.nih.gov/23602798